Bioharvest Sciences (BHST) Invested Capital (2023 - 2025)
Bioharvest Sciences has reported Invested Capital over the past 3 years, most recently at $25.6 million for Q4 2025.
- Quarterly results put Invested Capital at $25.6 million for Q4 2025, up 388.96% from a year ago — trailing twelve months through Dec 2025 was $25.6 million (up 388.96% YoY), and the annual figure for FY2025 was $25.6 million, up 388.96%.
- Invested Capital for Q4 2025 was $25.6 million at Bioharvest Sciences, up from $5.2 million in the prior quarter.
- Over the last five years, Invested Capital for BHST hit a ceiling of $25.6 million in Q4 2025 and a floor of -$83.5 million in Q4 2023.
- Median Invested Capital over the past 3 years was $5.2 million (2024), compared with a mean of -$17.6 million.
- Biggest five-year swings in Invested Capital: surged 106.27% in 2024 and later surged 388.96% in 2025.
- Bioharvest Sciences' Invested Capital stood at -$83.5 million in 2023, then soared by 106.27% to $5.2 million in 2024, then skyrocketed by 388.96% to $25.6 million in 2025.
- The last three reported values for Invested Capital were $25.6 million (Q4 2025), $5.2 million (Q4 2024), and -$83.5 million (Q4 2023) per Business Quant data.